1. Home
  2. AUID vs COCP Comparison

AUID vs COCP Comparison

Compare AUID & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.23

Market Cap

18.4M

Sector

Technology

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.34

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
COCP
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
15.6M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
AUID
COCP
Price
$1.23
$1.34
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
158.3K
196.1K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
54.65
EPS
N/A
N/A
Revenue
$2,040,660.00
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
130.20
N/A
52 Week Low
$0.84
$0.86
52 Week High
$5.82
$2.19

Technical Indicators

Market Signals
Indicator
AUID
COCP
Relative Strength Index (RSI) 48.34 46.47
Support Level $1.16 $1.28
Resistance Level $1.42 $1.42
Average True Range (ATR) 0.13 0.08
MACD 0.01 -0.02
Stochastic Oscillator 31.44 13.59

Price Performance

Historical Comparison
AUID
COCP

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: